Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 385, Issue 7, Pages 628-639Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra1909094
Keywords
-
Categories
Ask authors/readers for more resources
The ability to block specific cytokine pathways has revealed pathophysiological differences among autoimmune diseases, providing a framework for reclassification based on the efficacy of treatments like TNF inhibitors in certain diseases but not others.
Signature Cytokines and Immune-Mediated Inflammatory Diseases The ability to block specific cytokine pathways has revealed pathophysiological differences among autoimmune diseases (e.g., the efficacy of TNF inhibitors in arthritides and inflammatory bowel disorders and their inefficacy in giant-cell arteritis and multiple sclerosis), providing a framework for reclassification.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available